Special Drug Use Investigation for AMERGE® Tablet (Long-term)
NCT01332383
·
clinicaltrials.gov ↗
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine Disorders
Interventions
DRUG:
Naratriptan
Sponsor
GlaxoSmithKline